drugset / Trial / NCT05279963

EA for BPS: An RCT and Study for Central Mechanism

NCT05279963

RandomizedParallel-groupSingle-blindTreatment

Summary

This is a randomized controlled and assessor-blinded design trial to evaluate the efficacy and safety of acupuncture for bladder pain syndrome(BPS). All eligible participants will be randomly assigned to the medication group(n=21), EA group(n=42) and SA group(n=21) in a 1:2:1 allocation ratio. Participants will receive 4-week treatments phase followed by a 4-week follow-up phase. Outcomes will be assessed at baseline, during the treatment and at the end of the follow-up. Outcome assessors, data managers and statisticians will be blinded to the group allocation, while acupuncturists and participants will not be blinded for obvious reasons. Besides, fMRI will be used to collect spontaneous electrical activity of the brain of patients. In this trial, the investigators assume that electroacupuncture for BPS, compared to amitriptyline, is instrumental in improving symptoms such as pain, frequent micturition and emotional disorder.

Timeline

Start
2022-03-16
Primary completion
2024-12-24
Completion
2025-01-23

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amitriptyline Small molecule 25 mg Oral